A meta-analysis suggests adverse events are often falsely attributed to BP-lowering drugs, leaving patients undertreated.
Cyclic peptides, the WuXi analysis says, are a transformative class of therapeutics that combine the advantages of small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results